-
Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats.
Biochim Biophys Acta. 1996 Jun 7;1316(2):132-8
PMID: 8672550
-
Involvement of glomerular SREBP-1c in diabetic nephropathy.
Biochem Biophys Res Commun. 2007 Dec 21;364(3):502-8
PMID: 17961514
-
Scavenger receptors in atherosclerosis: beyond lipid uptake.
Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1702-11
PMID: 16728653
-
A simple method for the isolation and purification of total lipides from animal tissues.
J Biol Chem. 1957 May;226(1):497-509
PMID: 13428781
-
Atherosclerosis.
Nature. 2000 Sep 14;407(6801):233-41
PMID: 11001066
-
The molecular interactions between filtered proteins and proximal tubular cells in proteinuria.
Nephron Exp Nephrol. 2008;110(2):e67-71
PMID: 18849618
-
Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species.
J Biol Chem. 2000 Apr 28;275(17):12633-8
PMID: 10777555
-
Oxidative stress in uremia: nature, mechanisms, and potential consequences.
Semin Nephrol. 2004 Sep;24(5):469-73
PMID: 15490413
-
Downregulation of hepatic acyl-CoA:diglycerol acyltransferase in chronic renal failure.
Am J Physiol Renal Physiol. 2004 Jul;287(1):F90-4
PMID: 15010358
-
The role of the kidney in lipid metabolism.
Curr Opin Lipidol. 2005 Jun;16(3):301-6
PMID: 15891391
-
ATP-Binding cassette cholesterol transporters and cardiovascular disease.
Circ Res. 2006 Nov 10;99(10):1031-43
PMID: 17095732
-
Cellular lipid metabolism and the role of lipids in progressive renal disease.
Am J Nephrol. 2004 Jan-Feb;24(1):46-53
PMID: 14707435
-
Acute tubular injury causes dysregulation of cellular cholesterol transport proteins.
Am J Pathol. 2003 Jul;163(1):313-20
PMID: 12819036
-
SREBPs: the crossroads of physiological and pathological lipid homeostasis.
Trends Endocrinol Metab. 2008 Mar;19(2):65-73
PMID: 18291668
-
Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes.
Diabetes. 2005 Aug;54(8):2328-35
PMID: 16046298
-
Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions.
Circulation. 1999 Jun 22;99(24):3110-7
PMID: 10377073
-
Liver X receptor signaling pathways in cardiovascular disease.
Mol Endocrinol. 2003 Jun;17(6):985-93
PMID: 12690094
-
Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15597-602
PMID: 15496471
-
Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
J Am Soc Nephrol. 2004 Nov;15(11):2801-15
PMID: 15504933
-
ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure.
Am J Physiol Renal Physiol. 2004 Nov;287(5):F1038-43
PMID: 15280162
-
Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors.
Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1116-22
PMID: 10764682
-
Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus.
J Biol Chem. 2002 May 24;277(21):18919-27
PMID: 11875060
-
Role of altered renal lipid metabolism and the sterol regulatory element binding proteins in the pathogenesis of age-related renal disease.
Kidney Int. 2005 Dec;68(6):2608-20
PMID: 16316337
-
Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases.
Kidney Int. 1993 Apr;43(4):918-27
PMID: 8479130
-
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
Diabetes. 2006 Apr;55(4):885-93
PMID: 16567507
-
Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase.
Cell Res. 2008 Jun;18(6):609-21
PMID: 18504457
-
Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Diabetes Obes Metab. 2007 May;9(3):369-78
PMID: 17391165
-
Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
Cardiovasc Res. 2006 Jan;69(1):36-45
PMID: 16324688
-
Scavenging new insights into atherogenesis.
J Clin Invest. 2000 Apr;105(8):1039-41
PMID: 10772646
-
Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway.
J Biol Chem. 2005 Sep 16;280(37):32317-25
PMID: 16046411
-
Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Kidney Int. 2001 Jun;59(6):2192-6
PMID: 11380821
-
Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.
J Am Soc Nephrol. 2005 Aug;16(8):2385-94
PMID: 15944339
-
Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure.
Nephrol Dial Transplant. 1999 Jun;14(6):1462-6
PMID: 10383008
-
[Lipid peroxides in atherosclerotic diseases (author's transl)].
Nihon Ronen Igakkai Zasshi. 1978 May;15(3):187-91
PMID: 671818
-
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
Kidney Int. 2001 Jul;60(1):14-30
PMID: 11422732
-
Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells.
Am J Physiol Renal Physiol. 2004 Nov;287(5):F886-95
PMID: 15280160
-
Atherosclerosis. the road ahead.
Cell. 2001 Feb 23;104(4):503-16
PMID: 11239408
-
The fatty acid transport function of fatty acid-binding proteins.
Biochim Biophys Acta. 2000 Jun 26;1486(1):28-44
PMID: 10856711
-
Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease.
Lancet. 1982 Dec 11;2(8311):1309-11
PMID: 6128601
-
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11041-8
PMID: 10500120
-
Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years.
Kidney Int. 2001 Jun;59(6):2346-56
PMID: 11380839
-
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.
Cell. 1997 May 2;89(3):331-40
PMID: 9150132
-
Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
J Pharmacol Exp Ther. 2007 Oct;323(1):85-93
PMID: 17636006
-
CD36: implications in cardiovascular disease.
Int J Biochem Cell Biol. 2007;39(11):2012-30
PMID: 17466567
-
SREBP in signal transduction: cholesterol metabolism and beyond.
Curr Opin Cell Biol. 2007 Apr;19(2):215-22
PMID: 17303406
-
Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes.
Diabetes. 2006 Sep;55(9):2502-9
PMID: 16936198
-
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits.
Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):70-9
PMID: 10634802
-
Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):717-26
PMID: 12006382
-
Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure.
Metabolism. 2007 Dec;56(12):1714-8
PMID: 17998026
-
Lipotoxicity: when tissues overeat.
Curr Opin Lipidol. 2003 Jun;14(3):281-7
PMID: 12840659
-
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.
Kidney Int. 2002 Nov;62(5):1524-38
PMID: 12371953
-
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Transl Res. 2009 Feb;153(2):77-85
PMID: 19138652
-
High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Toxicol In Vitro. 2008 Jun;22(4):887-98
PMID: 18299183
-
Sterol regulatory element-binding proteins, liver X receptor, ABCA1 transporter, CD36, scavenger receptors A1 and B1 in nephrotic kidney.
Am J Nephrol. 2009;29(6):607-14
PMID: 19147991
-
The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide.
J Biol Chem. 2001 Apr 27;276(17):13750-5
PMID: 11278710
-
LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.
Pharmacol Ther. 2002 Jul;95(1):89-100
PMID: 12163130
-
SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.
Cell. 1994 Apr 8;77(1):53-62
PMID: 8156598
-
Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells.
Circulation. 2000 Jun 27;101(25):2889-95
PMID: 10869259
-
Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.
Am J Pathol. 2003 Jan;162(1):283-91
PMID: 12507911
-
Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER.
Cell. 2002 Aug 23;110(4):489-500
PMID: 12202038